These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy. Hsiao SJ; Zehir A; Sireci AN; Aisner DL J Mol Diagn; 2019 Jul; 21(4):553-571. PubMed ID: 31075511 [TBL] [Abstract][Full Text] [Related]
43. Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma. He H; Li W; Yan P; Bundschuh R; Killian JA; Labanowska J; Brock P; Shen R; Heerema NA; de la Chapelle A Thyroid; 2018 Jun; 28(6):748-754. PubMed ID: 29768105 [TBL] [Abstract][Full Text] [Related]
44. Fusion InPipe, an integrative pipeline for gene fusion detection from RNA-seq data in acute pediatric leukemia. Vicente-Garcés C; Maynou J; Fernández G; Esperanza-Cebollada E; Torrebadell M; Català A; Rives S; Camós M; Vega-García N Front Mol Biosci; 2023; 10():1141310. PubMed ID: 37363396 [TBL] [Abstract][Full Text] [Related]
46. RNA sequencing of sarcomas with simple karyotypes: identification and enrichment of fusion transcripts. Hofvander J; Tayebwa J; Nilsson J; Magnusson L; Brosjö O; Larsson O; von Steyern FV; Domanski HA; Mandahl N; Mertens F Lab Invest; 2015 Jun; 95(6):603-9. PubMed ID: 25867764 [TBL] [Abstract][Full Text] [Related]
47. FusionQ: a novel approach for gene fusion detection and quantification from paired-end RNA-Seq. Liu C; Ma J; Chang CJ; Zhou X BMC Bioinformatics; 2013 Jun; 14():193. PubMed ID: 23768108 [TBL] [Abstract][Full Text] [Related]
48. A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer. Kloosterman WP; Coebergh van den Braak RRJ; Pieterse M; van Roosmalen MJ; Sieuwerts AM; Stangl C; Brunekreef R; Lalmahomed ZS; Ooft S; van Galen A; Smid M; Lefebvre A; Zwartkruis F; Martens JWM; Foekens JA; Biermann K; Koudijs MJ; Ijzermans JNM; Voest EE Cancer Res; 2017 Jul; 77(14):3814-3822. PubMed ID: 28512242 [TBL] [Abstract][Full Text] [Related]
49. Discovery and Characterization of Recurrent, Targetable ALK Fusions in Leiomyosarcoma. Davis LE; Nusser KD; Przybyl J; Pittsenbarger J; Hofmann NE; Varma S; Vennam S; Debiec-Rychter M; van de Rijn M; Davare MA Mol Cancer Res; 2019 Mar; 17(3):676-685. PubMed ID: 30518629 [TBL] [Abstract][Full Text] [Related]
50. Accurate and efficient detection of gene fusions from RNA sequencing data. Uhrig S; Ellermann J; Walther T; Burkhardt P; Fröhlich M; Hutter B; Toprak UH; Neumann O; Stenzinger A; Scholl C; Fröhling S; Brors B Genome Res; 2021 Mar; 31(3):448-460. PubMed ID: 33441414 [TBL] [Abstract][Full Text] [Related]
51. Co-fuse: a new class discovery analysis tool to identify and prioritize recurrent fusion genes from RNA-sequencing data. Paisitkriangkrai S; Quek K; Nievergall E; Jabbour A; Zannettino A; Kok CH Mol Genet Genomics; 2018 Oct; 293(5):1217-1229. PubMed ID: 29882166 [TBL] [Abstract][Full Text] [Related]
52. Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer. Amatu A; Sartore-Bianchi A; Bencardino K; Pizzutilo EG; Tosi F; Siena S Ann Oncol; 2019 Nov; 30(Suppl_8):viii5-viii15. PubMed ID: 31738427 [TBL] [Abstract][Full Text] [Related]
53. NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer. Park DY; Choi C; Shin E; Lee JH; Kwon CH; Jo HJ; Kim HR; Kim HS; Oh N; Lee JS; Park OK; Park E; Park J; Shin JY; Kim JI; Seo JS; Park HD; Park J Oncotarget; 2016 Feb; 7(7):8399-412. PubMed ID: 26716414 [TBL] [Abstract][Full Text] [Related]
54. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Haas BJ; Dobin A; Li B; Stransky N; Pochet N; Regev A Genome Biol; 2019 Oct; 20(1):213. PubMed ID: 31639029 [TBL] [Abstract][Full Text] [Related]
55. LongGF: computational algorithm and software tool for fast and accurate detection of gene fusions by long-read transcriptome sequencing. Liu Q; Hu Y; Stucky A; Fang L; Zhong JF; Wang K BMC Genomics; 2020 Dec; 21(Suppl 11):793. PubMed ID: 33372596 [TBL] [Abstract][Full Text] [Related]
57. Feasibility and clinical utility of a pan-solid tumor targeted RNA fusion panel: A single center experience. Hindi I; Shen G; Tan Q; Cotzia P; Snuderl M; Feng X; Jour G Exp Mol Pathol; 2020 Jun; 114():104403. PubMed ID: 32061944 [TBL] [Abstract][Full Text] [Related]
58. Detection and genomic analysis of BRAF fusions in Juvenile Pilocytic Astrocytoma through the combination and integration of multi-omic data. Zwaig M; Baguette A; Hu B; Johnston M; Lakkis H; Nakada EM; Faury D; Juretic N; Ellezam B; Weil AG; Karamchandani J; Majewski J; Blanchette M; Taylor MD; Gallo M; Kleinman CL; Jabado N; Ragoussis J BMC Cancer; 2022 Dec; 22(1):1297. PubMed ID: 36503484 [TBL] [Abstract][Full Text] [Related]
59. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma. Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586 [TBL] [Abstract][Full Text] [Related]
60. The landscape of chimeric RNAs in bladder urothelial carcinoma. Zhu D; Singh S; Chen X; Zheng Z; Huang J; Lin T; Li H Int J Biochem Cell Biol; 2019 May; 110():50-58. PubMed ID: 30818082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]